Welcome to the website of the Federal Agency for Medicines and Health Products
Role of the FAMHP
We ensure the quality, safety and efficacy of medicines and health products in clinical development and on the market.
More information on www.influenza.be.
Reports on the adverse reactions reported at the Belgian level related to the vaccin Pandemrix used in Belgium as prevention of the A/H1N1v influenza pandemic (in French).
Weekly reports on the adverse reactions reported at the European level, related to the vaccines and antiviral medicines used in Europa as prevention and treatment of A/H1N1v influenza pandemic.
NEWS
-
Buying slimming products containing sibutramine on the internet: beware !
Following the recommendation of the European Medicines Agency (EMA) to suspend the marketing authorization of medicines containing sibutramine, the firm Abbott, at the request of the Federal Agency for Medicines and Health Products (FAMHP), withdrew Reductil from the market (the only medicine with sibutramine approved and marketed in Belgium) for security reasons. The FAMHP stresses the danger of buying online medicines with sibutramine.
read more -
Sibutramine (Reductil) : stopping product marketing
The European Medicines Agency (EMEA) has reviewed the safety of sibutramine, a medicine against excessive weight. Based on available data it woud seem that the cardiovascular risks associated with the use of this medicine outweigh its benefits. The EMEA recommends the suspension of the marketing authorisation of all medicines containing sibutramine that are marketed in the European Union. In Belgium sibutramine is marketed under the name Reductil.rketing
read more -
Human body material: legislation amendment
The law of 23rd December 2009 containing various provisions on public health, which was published in the “Moniteur belge” of 29th December 2009, came into force on 8th January 2010. It contains, amongst other things, provisions which amend the law of 19th December 2008 concerning the acquisition and use of human body material intended for human medical applications or for scientific research.
read more
